Indivior PLC (LON:INDV – Get Free Report) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,238 and traded as low as GBX 1,230. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares changing hands.
Indivior Price Performance
The company has a debt-to-equity ratio of -141.86, a current ratio of 0.90 and a quick ratio of 1.52. The company has a market cap of £1.93 billion, a PE ratio of -1,026.48, a PEG ratio of -5.57 and a beta of 0.19. The business’s fifty day simple moving average is GBX 1,238 and its two-hundred day simple moving average is GBX 1,238.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.
See Also
- Five stocks we like better than Indivior
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
